GT Biopharma, Inc. Contracts & Agreements

226 Contracts & Agreements
Browse by Contract Category
Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
First Amendment to Securities Purchase Agreement by and among GT Biopharma, Inc. and Purchasers (including Robert A. Marzilli)
Purchase Agreements
GT Biopharma, Inc.
Biotechnology
2025
Joinder to Registration Rights Agreement by GT Biopharma, Inc. and Robert A. Marzilli
Joinder Agreements
GT Biopharma, Inc.
Biotechnology
2025
Pre-Funded Warrant to Purchase Common Stock between GT Biopharma, Inc. and Holder (May 15, 2025)
Warrant Agreements
GT Biopharma, Inc.
Biotechnology
NY
2025
Common Shares Purchase Agreement between GT Biopharma, Inc. and Five Narrow Lane, L.P. and Bristol Capital, LLC
Purchase Agreements
GT Biopharma, Inc.
Biotechnology
NY
2025
Common Stock Purchase Warrant Agreement between GT Biopharma, Inc. and Holder (May 12, 2025)
Warrant Agreements
GT Biopharma, Inc.
Biotechnology
2025
GT Biopharma, Inc. Common Stock Vesting Warrant Agreement (May 12, 2025)
Warrant Agreements
GT Biopharma, Inc.
Biotechnology
2025
Securities Purchase Agreement between GT Biopharma, Inc. and Purchasers dated May 12, 2025
Purchase Agreements
GT Biopharma, Inc.
Biotechnology
NY
2025
Registration Rights Agreement between GT Biopharma, Inc. and Purchasers dated May 12, 2025
Registration Rights Agreements
GT Biopharma, Inc.
Biotechnology
2025
Voting Agreement Regarding Approval of GT Biopharma, Inc. Share Issuance under Securities Purchase Agreement
Voting Agreements
GT Biopharma, Inc.
Biotechnology
2025
Lock-Up Agreement between GT Biopharma, Inc. and Securityholders (May 12, 2025)
GT Biopharma, Inc.
Biotechnology
2025
Pre-Funded Common Stock Purchase Warrant between GT Biopharma, Inc. and Cytovance Biologics, Inc.
Warrant Agreements
GT Biopharma, Inc.
Biotechnology
2025
Series A Common Stock Purchase Warrant Agreement between GT Biopharma, Inc. and Holder
Warrant Agreements
GT Biopharma, Inc.
Biotechnology
NY
2025
Series B Common Stock Purchase Warrant Agreement between GT Biopharma, Inc. and Holder
Warrant Agreements
GT Biopharma, Inc.
Biotechnology
NY
2025
GT Biopharma, Inc. Inducement Offer to Exercise Common Stock Purchase Warrants Agreement (February 2025)
Warrant Agreements
GT Biopharma, Inc.
Biotechnology
2025
Common Stock Purchase Warrant Agreement between GT Biopharma, Inc. and Holder
Warrant Agreements
GT Biopharma, Inc.
Biotechnology
NY
2025
Pre-Funded Common Stock Purchase Warrant Agreement between GT Biopharma, Inc. and Holder
Warrant Agreements
GT Biopharma, Inc.
Biotechnology
NY
2025
Placement Agent Common Stock Purchase Warrant between GT Biopharma, Inc. and Placement Agent
Warrant Agreements
GT Biopharma, Inc.
Biotechnology
NY
2025
Securities Purchase Agreement between GT Biopharma, Inc. and Purchasers (2025)
Purchase Agreements
GT Biopharma, Inc.
Biotechnology
NY
2025
Placement Agency Agreement between GT Biopharma, Inc. and Roth Capital Partners, LLC (2025)
Underwriting Agreements
GT Biopharma, Inc.
Biotechnology
NY
2025
Investigator Initiated Clinical Trial Agreement between Regents of the University of Minnesota and GT Biopharma, Inc.
Collaboration Agreements
GT Biopharma, Inc.
Biotechnology
MN
2024
Amended and Restated Exclusive Patent License Agreement with the Regents of the University of Minnesota, dated May 13, 2024
License Agreements
GT Biopharma, Inc.
Biotechnology
2024
Sponsored Research Agreement with the Regents of the University of Minnesota dated May 20, 2024
GT Biopharma, Inc.
Biotechnology
2024
Employment Agreement between GT Biopharma, Inc. and Alan Urban (Chief Financial Officer)
Employment Agreements
GT Biopharma, Inc.
Biotechnology
CA
2024
Common Stock Purchase Warrant Agreement between GT Biopharma, Inc. and Holder (May 2024)
Warrant Agreements
GT Biopharma, Inc.
Biotechnology
2024
Securities Purchase Agreement between GT Biopharma, Inc. and Purchasers dated May 20, 2024
Purchase Agreements
GT Biopharma, Inc.
Biotechnology
NY
2024
Placement Agency Agreement between GT Biopharma, Inc. and Roth Capital Partners, LLC (May 21, 2024)
Underwriting Agreements
GT Biopharma, Inc.
Biotechnology
NY
2024
Amendment No. 1 to Settlement and Investment Agreement between GT Biopharma, Inc. and Cytovance Biologics, Inc.
Settlement Agreements
GT Biopharma, Inc.
Biotechnology
OK
2024
Amendment No. 1 to Employment Agreement with Michael Breen, dated as of June 17, 2022
Employment Agreements
GT Biopharma, Inc.
Biotechnology
2024
Amendment No. 2 to Services Agreement with Michael Breen, dated as of February 20, 2023
Services Agreements
GT Biopharma, Inc.
Biotechnology
2024
Amendment No. 1 to Employment Agreement with Manu Ohri, dated as of February 17, 2023
Employment Agreements
GT Biopharma, Inc.
Biotechnology
2024
Common Stock Purchase Warrant Agreement between GT Biopharma, Inc. and Holder (2023)
Warrant Agreements
GT Biopharma, Inc.
Biotechnology
2023
Pre-Funded Common Stock Purchase Warrant between GT Biopharma, Inc. and Holder (January 2023)
Warrant Agreements
GT Biopharma, Inc.
Biotechnology
2023
Placement Agent Common Stock Purchase Warrant between GT Biopharma, Inc. and H.C. Wainwright & Co., LLC
Warrant Agreements
GT Biopharma, Inc.
Biotechnology
2023
Securities Purchase Agreement between GT Biopharma, Inc. and Purchasers (December 2022)
Purchase Agreements
GT Biopharma, Inc.
Biotechnology
NY
2023
Board Service Agreement with Michael Breen dated November 11, 2020
Services Agreements
GT Biopharma, Inc.
Biotechnology
2022
Research Agreement with Regents of the University of Minnesota, dated June 16, 2021
GT Biopharma, Inc.
Biotechnology
2022
Securities Purchase Agreement between GT Biopharma, Inc. and Purchasers (2020)
Purchase Agreements
GT Biopharma, Inc.
Biotechnology
NY
2021
Second Amendment and Extension of Standstill and Forbearance Agreement between GT Biopharma, Inc. and Lender
Forbearance Agreements
GT Biopharma, Inc.
Biotechnology
2021
GT Biopharma, Inc. Warrant to Purchase Common Stock (Form of Warrant)
Warrant Agreements
GT Biopharma, Inc.
Biotechnology
NY
2021
GT Biopharma, Inc. Pre-Funded Warrant to Purchase Common Stock (Form of Warrant)
Warrant Agreements
GT Biopharma, Inc.
Biotechnology
NY
2021
Steve Weldon Letter of Resignation, dated November 11, 2020
GT Biopharma, Inc.
Biotechnology
2020
Securities Purchase Agreement between GT Biopharma, Inc. and Purchasers (November 6, 2020)
Purchase Agreements
GT Biopharma, Inc.
Biotechnology
NY
2020
Securities Purchase Agreement between GT Biopharma, Inc. and Purchasers (2020)
Purchase Agreements
GT Biopharma, Inc.
Biotechnology
NY
2020
Securities Purchase Agreement between GT Biopharma, Inc. and Purchasers (July 7, 2020)
Purchase Agreements
GT Biopharma, Inc.
Biotechnology
NY
2020
Standstill and Forbearance Agreement between GT Biopharma, Inc. and Noteholder
Forbearance Agreements
GT Biopharma, Inc.
Biotechnology
NY
2020
GT Biopharma, Inc. Pre-Funded Warrant to Purchase Common Stock (Empery Fund)
Warrant Agreements
GT Biopharma, Inc.
Biotechnology
NY
2020
Securities Purchase Agreement between GT Biopharma, Inc. and Purchasers dated January 30, 2020
Purchase Agreements
GT Biopharma, Inc.
Biotechnology
NY
2020
Securities Purchase Agreement between GT Biopharma, Inc. and Purchasers (April/May 2020)
Purchase Agreements
GT Biopharma, Inc.
Biotechnology
NY
2020
Securities Purchase Agreement between GT Biopharma, Inc. and Purchasers
Purchase Agreements
GT Biopharma, Inc.
Biotechnology
NY
2019
CONVERTIBLE NOTE DUE NOVEMBER ___, 2019
Note Agreements
GT Biopharma, Inc.
Biotechnology
NY
2019
SECURITIES PURCHASE AGREEMENT
Purchase Agreements
GT Biopharma, Inc.
Biotechnology
NY
2019
REGISTRATION RIGHTS AGREEMENT
Registration Rights Agreements
GT Biopharma, Inc.
Biotechnology
NY
2019
Form of Secured Convertible Note, dated February 4, 2019
Note Agreements
GT Biopharma, Inc.
Biotechnology
NY
2019
Securities Purchase Agreement by and among the Company and the Purchasers, dated February 4, 2019
Purchase Agreements
GT Biopharma, Inc.
Biotechnology
NY
2019
Securities Purchase Agreement between GT Biopharma, Inc. and Purchasers (September 24, 2018)
Purchase Agreements
GT Biopharma, Inc.
Biotechnology
NY
2018
Securities Purchase Agreement between GT Biopharma, Inc. and Purchasers (September 7, 2018)
Purchase Agreements
GT Biopharma, Inc.
Biotechnology
NY
2018
Securities Purchase Agreement between GT Biopharma, Inc. and Purchasers dated August 2, 2018
Purchase Agreements
GT Biopharma, Inc.
Biotechnology
NY
2018
GT Biopharma, Inc. Securities Purchase Agreement with Investors Dated January 22, 2018
Purchase Agreements
GT Biopharma, Inc.
Biotechnology
DE
2018
GT Biopharma, Inc. Warrant to Purchase Common Stock Agreement (2018)
Warrant Agreements
GT Biopharma, Inc.
Biotechnology
NY
2018
Executive Employment Agreement between GT Biopharma, Inc. and Shawn Cross
Employment Agreements
GT Biopharma, Inc.
Biotechnology
CA
2017
Agreement and Plan of Merger among GT Biopharma, Inc., GT Biopharma Merger Co., and Georgetown Translational Pharmaceuticals, Inc.
Merger Agreements
GT Biopharma, Inc.
Biotechnology
DE
2017
Certificate of Designation of Preferences, Rights and Limitations of Series J Convertible Preferred Stock of GT Biopharma, Inc.
Stock Agreements
GT Biopharma, Inc.
Biotechnology
2017
Employment Agreement between GT Biopharma, Inc., Georgetown Translational Pharmaceuticals, Inc., and Kathleen Clarence-Smith
Employment Agreements
GT Biopharma, Inc.
Biotechnology
DE
2017
Employment Agreement between GT Biopharma, Inc., Georgetown Translational Pharmaceuticals, Inc., and Anthony Cataldo
Employment Agreements
GT Biopharma, Inc.
Biotechnology
DE
2017
Employment Agreement between GT Biopharma, Inc., Georgetown Translational Pharmaceuticals, Inc., and Steven Weldon
Employment Agreements
GT Biopharma, Inc.
Biotechnology
DE
2017
Employment Agreement between GT Biopharma, Inc., Georgetown Translational Pharmaceuticals, Inc., and Dr. Raymond Urbanski
Employment Agreements
GT Biopharma, Inc.
Biotechnology
DE
2017
Note Conversion Agreement between GT Biopharma, Inc. and Multiple Investors (August 29, 2017)
Note Agreements
GT Biopharma, Inc.
Biotechnology
NY
2017
Warrant Exercise Agreement between GT Biopharma, Inc. and Warrant Holders (August 29, 2017)
Warrant Agreements
GT Biopharma, Inc.
Biotechnology
NY
2017
Preferred Stock Exchange Agreement between GT Biopharma, Inc. and Preferred Stockholders
Exchange Agreements
GT Biopharma, Inc.
Biotechnology
NY
2017
Amendment Agreement to Note Conversion Agreements between GT Biopharma Inc. and Note Holders (October 2017)
Modification Agreements
GT Biopharma, Inc.
Biotechnology
2017
Amendment Agreement to Warrant Exercise Agreements between GT Biopharma Inc. and Warrant Holders
Modification Agreements
GT Biopharma, Inc.
Biotechnology
2017
Amendment Agreement to Preferred Stock Exchange Agreements between GT Biopharma Inc. and Preferred Stockholders
Modification Agreements
GT Biopharma, Inc.
Biotechnology
2017
Exclusive License Agreement between ID4 Pharma, LLC and Oxis Biotech, Inc. (December 31, 2014)
License Agreements
GT Biopharma, Inc.
Biotechnology
CA
2017
License Agreement between Oxis Biotech, Inc. and MultiCell Immunotherapeutics, Inc. for Antibody-Drug Conjugate Technology
License Agreements
GT Biopharma, Inc.
Biotechnology
2017
Exclusive Patent License Agreement between Regents of the University of Minnesota and Oxis Biotech, Inc.
License Agreements
GT Biopharma, Inc.
Biotechnology
MN
2017
Exclusive License Agreement between Daniel A. Vallera, Ph.D., Jeffrey Lion, and Oxis Biotech, Inc.
License Agreements
GT Biopharma, Inc.
Biotechnology
CA
2017
Securities Purchase Agreement between OXIS International, Inc. and Purchasers (January 9, 2017)
Purchase Agreements
GT Biopharma, Inc.
Biotechnology
NY
2017
Warrant Agreement between OXIS International, Inc. and Holder for Common Stock Purchase
Warrant Agreements
GT Biopharma, Inc.
Biotechnology
2017
Warrant Exercise Agreement between OXIS International, Inc. and Multiple Warrant Holders (January 7, 2016)
Warrant Agreements
GT Biopharma, Inc.
Biotechnology
DE
2016
Oxis International, Inc. Series A Warrant Certificate Agreement
Warrant Agreements
GT Biopharma, Inc.
Biotechnology
DE
2016
Warrant Exercise Agreement between OXIS International, Inc. and Multiple Warrant Holders (January 7, 2016)
Warrant Agreements
GT Biopharma, Inc.
Biotechnology
DE
2016
Amended Employment Agreement between OXIS International Inc. and Steven W. Weldon
Employment Agreements
GT Biopharma, Inc.
Biotechnology
NY
2015
Amended Employment Agreement between OXIS International Inc. and Anthony J. Cataldo
Employment Agreements
GT Biopharma, Inc.
Biotechnology
NY
2015
10% Senior Convertible Debenture Agreement between OXIS International, Inc. and Holder
Debenture Agreements
GT Biopharma, Inc.
Biotechnology
NY
2015
Securities Purchase Agreement between OXIS International, Inc. and Purchaser
Purchase Agreements
GT Biopharma, Inc.
Biotechnology
NY
2015
Common Stock Purchase Warrant Agreement between OXIS International, Inc. and Holder (March 2015)
Warrant Agreements
GT Biopharma, Inc.
Biotechnology
2015
Research Agreement between Oxis Biotech, Inc. and MultiCell Immunotherapeutics, Inc. (MCIT)
Collaboration Agreements
GT Biopharma, Inc.
Biotechnology
2015
Employment Agreement between OXIS International Inc. and Anthony J. Cataldo (CEO)
Employment Agreements
GT Biopharma, Inc.
Biotechnology
NY
2015
Amended Executive Employment Agreement between OXIS International, Inc. and Steve Weldon
Employment Agreements
GT Biopharma, Inc.
Biotechnology
FL
2015
Executive Employment Agreement between OXIS International, Inc. and Steve Weldon
Employment Agreements
GT Biopharma, Inc.
Biotechnology
CO
2014
Securities Purchase Agreement between OXIS International, Inc. and Purchasers (July 24, 2014)
Purchase Agreements
GT Biopharma, Inc.
Biotechnology
NY
2014
OXIS International, Inc. 10% Senior Convertible Debenture Due July 24, 2016
Debenture Agreements
GT Biopharma, Inc.
Biotechnology
NY
2014
Common Stock Purchase Warrant Agreement between OXIS International, Inc. and Holder (July 24, 2014)
Warrant Agreements
GT Biopharma, Inc.
Biotechnology
2014
Loan Agreement between OXIS International Inc. and Lenders dated December 3, 2012
Loan Agreements
GT Biopharma, Inc.
Biotechnology
DE
2012
Settlement Agreement and Mutual General Release between OXIS International, Inc. and Bristol Investment Fund, Ltd. (August 8, 2012)
Settlement Agreements
GT Biopharma, Inc.
Biotechnology
NY
2012
Oxis International, Inc. 8% Two-Year Convertible Debenture Agreement
Debenture Agreements
GT Biopharma, Inc.
Biotechnology
NY
2012
Series A Common Stock Purchase Warrant Agreement between OXIS International, Inc. and Holder
Warrant Agreements
GT Biopharma, Inc.
Biotechnology
2012
Series B Common Stock Purchase Warrant Agreement between OXIS International, Inc. and Holder
Warrant Agreements
GT Biopharma, Inc.
Biotechnology
2012
Standstill and Forbearance Agreement between OXIS International, Inc. and Bristol Investment Fund, Ltd. dated May 15, 2012
Forbearance Agreements
GT Biopharma, Inc.
Biotechnology
NY
2012
Joint Venture Agreement among John E. Repine, M.D., Oxis International, Inc., and Ergo ARDS, LLC (June 29, 2011)
Joint Venture Agreements
GT Biopharma, Inc.
Biotechnology
CO
2011
Oxis International, Inc. 2010 Equity Incentive Plan
Bonus & Incentive Agreements
GT Biopharma, Inc.
Biotechnology
2011
Commitment Letter for Subordinated Bridge Revolving Line of Credit between Gemini Pharmaceuticals, Inc. and Oxis International, Inc.
Credit Agreements
GT Biopharma, Inc.
Biotechnology
CA
2011
Series I Preferred Stock Purchase Agreement between Oxis International, Inc. and Purchaser (November 10, 2010)
Purchase Agreements
GT Biopharma, Inc.
Biotechnology
DE
2011
First Amendment to 0% Convertible Debenture between Oxis International, Inc. and Debenture Holders
Debenture Agreements
GT Biopharma, Inc.
Biotechnology
2011
Escrow Agreement among Oxis International, Theorem Capital LLC, Theorem Group LLC, and Law Offices of Jacques Chen
Escrow Agreements
GT Biopharma, Inc.
Biotechnology
2010
Employment Agreement between Oxis International, Inc. and Michael Handelman dated March 11, 2010
Employment Agreements
GT Biopharma, Inc.
Biotechnology
CA
2010
Employment Agreement between OXIS International, Inc. and Anthony J. Cataldo, dated March 29, 2010
Employment Agreements
GT Biopharma, Inc.
Biotechnology
CA
2010
Advisory Agreement between Oxis International, Inc. and Gary M. Post
Advisory Agreements
GT Biopharma, Inc.
Biotechnology
CA
2010
Employment Agreement between Oxis International, Inc. and Bernard Landes dated March 11, 2010
Employment Agreements
GT Biopharma, Inc.
Biotechnology
CA
2010
Exchange Agreement between Oxis International, Inc. and Theorem Group, LLC (Series G for Series H Preferred Stock)
Exchange Agreements
GT Biopharma, Inc.
Biotechnology
DE
2010
Securities Purchase Agreement between OXIS International, Inc. and Purchasers (October 1, 2009)
Purchase Agreements
GT Biopharma, Inc.
Biotechnology
DE
2009
OXIS International, Inc. 0% Convertible Debenture Due October 1, 2011
Debenture Agreements
GT Biopharma, Inc.
Biotechnology
NY
2009
Series A Common Stock Purchase Warrant Agreement between OXIS International, Inc. and Holder
Warrant Agreements
GT Biopharma, Inc.
Biotechnology
2009
Series B Common Stock Purchase Warrant Agreement between OXIS International, Inc. and Holder
Warrant Agreements
GT Biopharma, Inc.
Biotechnology
2009
Waiver Agreement between Oxis International, Inc. and Bristol Investment Fund Ltd. (October 1, 2009)
Waiver Agreements
GT Biopharma, Inc.
Biotechnology
2009
Standstill and Forbearance Agreement between OXIS International, Inc. and Bristol Investment Fund, Ltd.
Forbearance Agreements
GT Biopharma, Inc.
Biotechnology
NY
2009
Convertible Demand Promissory Note between Oxis International, Inc. and Bristol Investment Fund, Ltd. dated April 7, 2009
Note Agreements
GT Biopharma, Inc.
Biotechnology
NY
2009
Common Stock Purchase Warrant Agreement between Oxis International, Inc. and Bristol Investment Fund, Ltd. dated April 2009
Warrant Agreements
GT Biopharma, Inc.
Biotechnology
2009
Asset Purchase Agreement between Percipio Biosciences, Inc. and Oxis International, Inc. dated December 11, 2008
Purchase Agreements
GT Biopharma, Inc.
Biotechnology
DE
2008
Secured Promissory Note between Percipio Biosciences, Inc. and Oxis International, Inc. dated December 11, 2008
Note Agreements
GT Biopharma, Inc.
Biotechnology
DE
2008
Debt Conversion Agreement between Oxis International, Inc. and Bristol Investment Fund, Ltd. dated December 4, 2008
Exchange Agreements
GT Biopharma, Inc.
Biotechnology
2008
Notice of Disposition of Collateral between Bristol Capital Advisors, LLC and Oxis International, Inc. (June 19, 2008)
GT Biopharma, Inc.
Biotechnology
2008
Notification of Disposition of Collateral by Bristol Investment Fund, Ltd. to Oxis International, Inc.
Security Agreements
GT Biopharma, Inc.
Biotechnology
2008
Amendment to Advisory Agreement between Oxis International, Inc. and Ambient Advisors LLC
Advisory Agreements
GT Biopharma, Inc.
Biotechnology
2007
Employment Agreement between OXIS International, Inc. and Marvin S. Hausman, M.D. dated November 6, 2006
Employment Agreements
GT Biopharma, Inc.
Biotechnology
CA
2006
Advisory Agreement between Oxis International, Inc. and Ambient Advisors LLC dated November 6, 2006
Advisory Agreements
GT Biopharma, Inc.
Biotechnology
2006
Consulting Agreement between Oxis International, Inc. and John E. Repine, M.D. dated November 6, 2006
Consulting Agreements
GT Biopharma, Inc.
Biotechnology
2006
Securities Purchase Agreement between Oxis International, Inc. and Purchasers (October 25, 2006)
Purchase Agreements
GT Biopharma, Inc.
Biotechnology
2006
Secured Convertible Debenture Agreement between Oxis International, Inc. and Holder (Due October 25, 2008)
Debenture Agreements
GT Biopharma, Inc.
Biotechnology
2006
Oxis International, Inc. Series A-E Common Stock Purchase Warrant Agreement
Warrant Agreements
GT Biopharma, Inc.
Biotechnology
2006
Registration Rights Agreement between Oxis International, Inc. and Purchasers (October 25, 2006)
Registration Rights Agreements
GT Biopharma, Inc.
Biotechnology
2006
Security Agreement between Oxis International, Inc., Subsidiaries, and Holders of Secured Convertible Debentures
Security Agreements
GT Biopharma, Inc.
Biotechnology
2006
Renewal and Modification Promissory Note between Oxis International, Inc. and Fagan Capital Inc. dated June 2, 2006
Note Agreements
GT Biopharma, Inc.
Biotechnology
TX
2006
Oxis International Inc. Common Stock Purchase Warrant Agreement with Fagan Capital Inc.
Warrant Agreements
GT Biopharma, Inc.
Biotechnology
2006
Amendment No. 2 to Exclusive License and Supply Agreement between OXIS International and HaptoGuard, Inc.
License Agreements
GT Biopharma, Inc.
Biotechnology
2006
Mutual Services Agreement between OXIS International, Inc. and Bio Check, Inc. dated June 23, 2006
Services Agreements
GT Biopharma, Inc.
Biotechnology
CA
2006
Advisory Services Agreement between OXIS International, Inc. and Ambient Advisors, LLC
Advisory Agreements
GT Biopharma, Inc.
Biotechnology
2006
Promissory Note between OXIS International, Inc. and Fagan Capital Inc. dated March 31, 2006
Note Agreements
GT Biopharma, Inc.
Biotechnology
DE
2006
Promissory Note between OXIS International, Inc. and Steven T. Guillen dated March 10, 2006
Note Agreements
GT Biopharma, Inc.
Biotechnology
CA
2006
Office Lease Agreement between Westcore Peninsula Vintage, LLC and Oxis International, Inc. for Suite B, 323 Vintage Park Drive
Lease Agreements
GT Biopharma, Inc.
Biotechnology
CA
2006
Oxis International, Inc. Employment Letter Agreement with Michael D. Centron (CFO)
Employment Agreements
GT Biopharma, Inc.
Biotechnology
CA
2006
Consulting Agreement between Oxis International, Inc. and NW Medical Research Partners, Inc.
Consulting Agreements
GT Biopharma, Inc.
Biotechnology
OR
2005
Tenth Amendment to Lease Agreement between Rosan, Inc. and Oxis International, Inc.
Lease Agreements
GT Biopharma, Inc.
Biotechnology
2005
Employment Letter Agreement between OXIS International, Inc. and Steven T. Guillen (President & CEO)
Employment Agreements
GT Biopharma, Inc.
Biotechnology
OR
2005
Stock Purchase Agreement between OXIS International, Inc. and Steven T. Guillen dated February 28, 2005
Stock Agreements
GT Biopharma, Inc.
Biotechnology
OR
2005
Addendum to Executive Separation and Employment Agreement between OXIS International, Inc. and Ray R. Rogers
Separation Agreements
GT Biopharma, Inc.
Biotechnology
2001
Executive Employment Agreement between OXIS International, Inc. and Jon S. Pitcher
Employment Agreements
GT Biopharma, Inc.
Biotechnology
OR
2000
Executive Employment Agreement between OXIS International, Inc. and Humberto V. Reyes
Employment Agreements
GT Biopharma, Inc.
Biotechnology
OR
2000
Description of Securities Registered Under Section 12 of the Securities Exchange Act of 1934
Equity Distribution Agreements
GT Biopharma, Inc.
Biotechnology
2023
Settlement and Investment Agreement dated August 24, 2022, by and between GT Biopharma, Inc. and Cytovance Biologics, Inc
Settlement Agreements
GT Biopharma, Inc.
Biotechnology
2022
Employment Agreement between GT Biopharma, Inc. and Manu Ohri (Chief Financial Officer)
Employment Agreements
GT Biopharma, Inc.
Biotechnology
CA
2022
Exclusive License Agreement with Regents of the University of Minnesota, dated March 26, 2021
License Agreements
GT Biopharma, Inc.
Biotechnology
2022
Sublease Agreement dated November, 2021, between Aimmune Therapeutics, Inc. (Sublandlord) and GT Biopharma, Inc. (Subtenant)
Lease Agreements
GT Biopharma, Inc.
Biotechnology
2022
Employment Agreement with Michael Breen, entered into as of December 31, 2021 with an effective date of November 8, 2021
Employment Agreements
GT Biopharma, Inc.
Biotechnology
2022
Amended and Restated Employment Agreement between GT Biopharma, Inc. and Anthony J. Cataldo (April 23, 2021)
Employment Agreements
GT Biopharma, Inc.
Biotechnology
CA
2021
Amended and Restated Employment Agreement between GT Biopharma, Inc. and Michael Handelman (April 23, 2021)
Employment Agreements
GT Biopharma, Inc.
Biotechnology
CA
2021
Amended and Restated Employment Agreement between GT Biopharma, Inc. and Dr. Gregory Berk, dated April 23, 2021
Employment Agreements
GT Biopharma, Inc.
Biotechnology
MA
2021
Certificate of Designation of Series K Preferred Stock of GT Biopharma, Inc.
Articles of Amendment
GT Biopharma, Inc.
Biotechnology
2021
Amendment to Convertible Note between GT Biopharma, Inc. and Alto Opportunity Master Fund, SPC
Note Agreements
GT Biopharma, Inc.
Biotechnology
2021
GT Biopharma, Inc. Form of December 2020 / January 2021 Convertible Note Agreement
Note Agreements
GT Biopharma, Inc.
Biotechnology
NY
2021
Underwriting Agreement between GT Biopharma, Inc. and Roth Capital Partners, LLC (2021)
Underwriting Agreements
GT Biopharma, Inc.
Biotechnology
NY
2021
Board Service Agreement between GT Biopharma, Inc. and Rajesh Shrotriya, Dated January 12, 2021
Services Agreements
GT Biopharma, Inc.
Biotechnology
2021
Board Service Agreement between GT Biopharma, Inc. and Michael Breen, dated January 12, 2021
Services Agreements
GT Biopharma, Inc.
Biotechnology
2021
Amendment to Convertible Note between GT Biopharma, Inc. and Alto Opportunity Master Fund, SPC
Modification Agreements
GT Biopharma, Inc.
Biotechnology
2021
Securities Purchase Agreement between GT Biopharma, Inc. and Purchasers (December 2020/January 2021 Notes)
Purchase Agreements
GT Biopharma, Inc.
Biotechnology
NY
2021
GT Biopharma, Inc. Form of December 2020 / January 2021 Convertible Note Agreement
Note Agreements
GT Biopharma, Inc.
Biotechnology
NY
2021
Amendment to Convertible Note between GT Biopharma, Inc. and Holder (Effective January 2021)
Modification Agreements
GT Biopharma, Inc.
Biotechnology
2021
Settlement Agreement among Alto Opportunity Master Fund, GT Biopharma Inc., Anthony Cataldo, and Paul Kessler
Settlement Agreements
GT Biopharma, Inc.
Biotechnology
NY
2020
GT Biopharma, Inc. $500,000 Convertible Note Due January 31, 2021 with Alto Opportunity Master Fund
Note Agreements
GT Biopharma, Inc.
Biotechnology
NY
2020
Amendment to Convertible Note and Standstill Agreement between GT Biopharma, Inc. and Note Holder
Note Agreements
GT Biopharma, Inc.
Biotechnology
2020
Settlement Agreement between GT Biopharma Inc. and Adam Kasower, East Ventures, SV Booth Investments III, and Theorem Group
Settlement Agreements
GT Biopharma, Inc.
Biotechnology
NY
2020
Convertible Settlement Note Agreement between GT Biopharma, Inc. and Theorem Group, LLC (Due January 31, 2021)
Note Agreements
GT Biopharma, Inc.
Biotechnology
NY
2020
Board Service Agreement between GT Biopharma, Inc. and Bruce Wendel (Director)
Services Agreements
GT Biopharma, Inc.
Biotechnology
2020
Board Service Agreement between GT Biopharma, Inc. and Gregory Berk (Director)
Services Agreements
GT Biopharma, Inc.
Biotechnology
2020
Consultant Agreement between GT Biopharma, Inc. and Michael Handelman (Interim CFO Services)
Consulting Agreements
GT Biopharma, Inc.
Biotechnology
DE
2020
GT Biopharma, Inc. Convertible Note Agreement (2020)
Note Agreements
GT Biopharma, Inc.
Biotechnology
NY
2020
Master Services Agreement between GT Biopharma, Inc. and Cytovance Biologics, Inc.
Services Agreements
GT Biopharma, Inc.
Biotechnology
DE
2020
Secured Convertible Note Agreement between GT Biopharma, Inc. and Noteholder
Note Agreements
GT Biopharma, Inc.
Biotechnology
NY
2020
Employment Agreement between GT Biopharma, Inc. and Anthony J. Cataldo
Employment Agreements
GT Biopharma, Inc.
Biotechnology
DE
2020
Employment Agreement between GT Biopharma, Inc. and Steven Weldon (CFO)
Employment Agreements
GT Biopharma, Inc.
Biotechnology
DE
2020
GT Biopharma, Inc. Secured Convertible Note Agreement
Note Agreements
GT Biopharma, Inc.
Biotechnology
NY
2020
Registration Rights Agreement between GT Biopharma, Inc. and Purchasers (July 7, 2020)
Registration Rights Agreements
GT Biopharma, Inc.
Biotechnology
NY
2020
Settlement Agreement among Empery Funds, GT Biopharma Inc., Anthony Cataldo, and Paul Kessler
Settlement Agreements
GT Biopharma, Inc.
Biotechnology
DE
2020
GT Biopharma, Inc. Convertible Note Due December 19, 2020
Note Agreements
GT Biopharma, Inc.
Biotechnology
NY
2020
Registration Rights Agreement between GT Biopharma, Inc. and Purchasers (January 30, 2020)
Registration Rights Agreements
GT Biopharma, Inc.
Biotechnology
NY
2020
GT Biopharma, Inc. Convertible Note Agreement, Dated January 30, 2020
Note Agreements
GT Biopharma, Inc.
Biotechnology
NY
2020
Registration Rights Agreement between GT Biopharma, Inc. and Purchasers (April/May 2020)
Registration Rights Agreements
GT Biopharma, Inc.
Biotechnology
NY
2020
GT Biopharma, Inc. Convertible Note Agreement (April/May 2020)
Note Agreements
GT Biopharma, Inc.
Biotechnology
NY
2020
Clinical Trial Agreement between GT Biopharma, Inc. and Regents of the University of Minnesota
Collaboration Agreements
GT Biopharma, Inc.
Biotechnology
MN
2020
Secured Convertible Note Agreement between GT Biopharma, Inc. and Holder
Note Agreements
GT Biopharma, Inc.
Biotechnology
NY
2019
Registration Rights Agreement between GT Biopharma, Inc. and Purchasers
Registration Rights Agreements
GT Biopharma, Inc.
Biotechnology
NY
2019
Security Agreement by and among the Company, Alpha Capital Anstalt, as collateral agent, and the Purchasers, dated February 4, 2019
Security Agreements
GT Biopharma, Inc.
Biotechnology
NY
2019
Registration Rights Agreement by and among the Company and the Purchasers, dated February 4, 2019
Registration Rights Agreements
GT Biopharma, Inc.
Biotechnology
NY
2019
Executive Employment Agreement with Dr. Urbanski
Employment Agreements
GT Biopharma, Inc.
Biotechnology
2018
GT Biopharma, Inc. 10% Senior Convertible Debenture Due September 24, 2019
Debenture Agreements
GT Biopharma, Inc.
Biotechnology
NY
2018
GT Biopharma, Inc. 10% Senior Convertible Debenture Due 2019
Debenture Agreements
GT Biopharma, Inc.
Biotechnology
NY
2018
Stock Pledge Agreement between GT Biopharma, Inc. Affiliates and Grushko & Mittman, P.C. (as Collateral Agent)
Pledge Agreements
GT Biopharma, Inc.
Biotechnology
NY
2018
GT Biopharma, Inc. 10% Senior Convertible Debenture Due August 2, 2019
Debenture Agreements
GT Biopharma, Inc.
Biotechnology
NY
2018
Indemnification Agreement between GT Biopharma, Inc. and Director or Officer
Indemnification Agreements
GT Biopharma, Inc.
Biotechnology
DE
2018
Executive Employment Agreement between GT Biopharma, Inc. and Shawn Cross
Employment Agreements
GT Biopharma, Inc.
Biotechnology
CA
2018
First Amendment to Employment Agreement by and among GT Biopharma, Inc., Georgetown Translational Pharmaceuticals, Inc., and Kathleen Clarence-Smith
Employment Agreements
GT Biopharma, Inc.
Biotechnology
2018
Consultant Agreement between GT Biopharma, Inc., Georgetown Translational Pharmaceuticals, Inc., and Anthony J. Cataldo
Consulting Agreements
GT Biopharma, Inc.
Biotechnology
DE
2018
Registration Rights Agreement between GT Biopharma, Inc. and Investors (Buyers)
Registration Rights Agreements
GT Biopharma, Inc.
Biotechnology
NY
2018
GT Biopharma, Inc. Senior Convertible Note (Form of Note)
Note Agreements
GT Biopharma, Inc.
Biotechnology
NY
2018
Exclusive Patent License Agreement between Regents of the University of Minnesota and Oxis Biotech, Inc.
License Agreements
GT Biopharma, Inc.
Biotechnology
MN
2017
License Agreement Between Daniel A. Vallera, Jeffrey Lion, and Oxis Biotech, Inc. for Technology Rights
License Agreements
GT Biopharma, Inc.
Biotechnology
CA
2017
OXIS International, Inc. 10% Senior Convertible Debenture Due June 30, 2017
Debenture Agreements
GT Biopharma, Inc.
Biotechnology
NY
2017
Exclusive License Agreement between Daniel A. Vallera, Jeffrey Lion, and Oxis Biotech, Inc.
License Agreements
GT Biopharma, Inc.
Biotechnology
CA
2016
Exclusive License Agreement between ID4 Pharma, LLC and Oxis Biotech, Inc.
License Agreements
GT Biopharma, Inc.
Biotechnology
CA
2016
Exclusive Patent License Agreement between Regents of the University of Minnesota and Oxis Biotech, Inc.
License Agreements
GT Biopharma, Inc.
Biotechnology
MN
2016
Exclusive License Agreement between Daniel A. Vallera, Jeffrey Lion, and Oxis Biotech, Inc.
License Agreements
GT Biopharma, Inc.
Biotechnology
CA
2016
License Agreement Between Oxis Biotech, Inc. and MultiCell Immunotherapeutics, Inc. for Antibody-Drug Conjugate Technology
License Agreements
GT Biopharma, Inc.
Biotechnology
2016
Exclusive License Agreement between ID4 Pharma, LLC and Oxis Biotech, Inc. (December 31, 2014)
License Agreements
GT Biopharma, Inc.
Biotechnology
CA
2016
Exclusive Patent License Agreement between Regents of the University of Minnesota and Oxis Biotech, Inc.
License Agreements
GT Biopharma, Inc.
Biotechnology
MN
2016
Exclusive License Agreement between Daniel A. Vallera, Ph.D., Jeffrey Lion, and Oxis Biotech, Inc.
License Agreements
GT Biopharma, Inc.
Biotechnology
CA
2016
License Agreement between Oxis Biotech, Inc. and MultiCell Immunotherapeutics, Inc. for Antibody-Drug Conjugate Technology
License Agreements
GT Biopharma, Inc.
Biotechnology
2016
Note Conversion Agreement between OXIS International, Inc. and Multiple Investors (January 8, 2016)
Note Agreements
GT Biopharma, Inc.
Biotechnology
DE
2016
Preferred Stock Exchange Agreement between OXIS International, Inc. and Preferred Stockholders
Exchange Agreements
GT Biopharma, Inc.
Biotechnology
DE
2016
Placement Agreement between OXIS International, Inc. and Rodman & Renshaw (H.C. Wainwright & Co., LLC) dated July 12, 2016
Underwriting Agreements
GT Biopharma, Inc.
Biotechnology
NY
2016
Certificate of Designation of Series J Convertible Preferred Stock of Oxis International, Inc.
Stock Agreements
GT Biopharma, Inc.
Biotechnology
2016
Certificate of Designation for Series J Convertible Preferred Stock of Oxis International, Inc.
Stock Agreements
GT Biopharma, Inc.
Biotechnology
2016
Amended Employment Agreement between OXIS International Inc. and Steven W Weldon (CFO)
Employment Agreements
GT Biopharma, Inc.
Biotechnology
NY
2016
Amended Employment Agreement between OXIS International Inc. and Anthony J Cataldo (CEO)
Employment Agreements
GT Biopharma, Inc.
Biotechnology
NY
2016
Amendment to Note Conversion Agreement between OXIS International, Inc. and Investors
Modification Agreements
GT Biopharma, Inc.
Biotechnology
DE
2016
Note Conversion Agreement between OXIS International, Inc. and Multiple Investors (January 8, 2016)
Note Agreements
GT Biopharma, Inc.
Biotechnology
DE
2016
Preferred Stock Exchange Agreement between OXIS International, Inc. and Preferred Stockholders
Exchange Agreements
GT Biopharma, Inc.
Biotechnology
DE
2016